Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
An Open-Label Extension (OLE), Long-term Safety and Tolerability Study of Plecanatide in Patients With Chronic Idiopathic Constipation (CIC)
1 other identifier
interventional
2,370
2 countries
220
Brief Summary
This is a multi-center, open-label, 52-week safety and tolerability study of plecanatide in patients with Chronic Idiopathic Constipation (CIC).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Aug 2013
Typical duration for phase_3
220 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2013
CompletedFirst Submitted
Initial submission to the registry
August 7, 2013
CompletedFirst Posted
Study publicly available on registry
August 9, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2016
CompletedResults Posted
Study results publicly available
July 2, 2019
CompletedJuly 2, 2019
June 1, 2019
2.4 years
August 7, 2013
December 13, 2018
June 11, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Number of Patients With at Least One Treatment-Emergent Adverse Event (TEAE)
All clinically significant findings upon Physical Examinations of the Safety Population during the treatment period were reported as TEAEs. Safety was evaluated based on number of patients who experienced at least one TEAE.
From first dose up to 72 weeks
Number of Patients With at Least One Treatment-Emergent Adverse Event (TEAE) Leading to Discontinuation of Plecanatide
Tolerability was evaluated based on number of patients who experienced at least one TEAE leading to discontinuation of the study drug
From first dose up to 72 weeks
Summary of Vital Signs at >Day 364 - Blood Pressure (Systolic and Diastolic; mmHg)
The vital signs included in the assessments were blood pressure (systolic and diastolic; mmHg), heart rate (beats per minute), body temperature (°C) and respiration rate (breaths per minute).
From first dose up to 72 weeks
Summary of Vital Signs at >Day 364 - Heart Rate (Beats Per Minute)
The vital signs included in the assessments were blood pressure (systolic and diastolic; mmHg), heart rate (beats per minute), body temperature (°C) and respiration rate (breaths per minute).
From first dose up to 72 weeks
Summary of Vital Signs at >Day 364 - Body Temperature (°C)
The vital signs included in the assessments were blood pressure (systolic and diastolic; mmHg), heart rate (beats per minute), body temperature (°C) and respiration rate (breaths per minute).
From first dose up to 72 weeks
Summary of Vital Signs at >Day 364 - Respiration Rate (Breaths Per Minute)
The vital signs included in the assessments were blood pressure (systolic and diastolic; mmHg), heart rate (beats per minute), body temperature (°C) and respiration rate (breaths per minute).
From first dose up to 72 weeks
Summary of ECG Results Shift From Baseline at > Day 364
Baseline was defined as the last non-missing value collected prior to first dose of study drug)
From first dose up to 72 weeks
Summary of Treatment-Emergent Laboratory Abnormalities With At Least a 1-grade Shift From Baseline
Baseline was defined as the last non-missing value collected prior to first dose of study drug within a given entry into the study. The Common Terminology Criteria for Adverse Events (CTCAE), Grades 1 through 5 were used for descriptions of severity for each Adverse Event (AE): Grade 1 - Mild; asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated; Grade 2 - Moderate; minimal, local or noninvasive intervention indicated; limiting age appropriate instrumental Activities of Daily Living (ADL); Grade 3 - Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of hospitalization indicated; disabling; limiting self care ADL; Grade 4 - Life-threatening consequences; urgent intervention indicated; Grade 5 - Death related to AE.
From first dose up to 72 weeks
Secondary Outcomes (4)
Summary of Patient Patient Global Assessment (PGA) for Constipation Severity at > Day 364
Form first dose up to 72 weeks
Summary of Patient Global Assessment (PGA) for Constipation - Change From Baseline to > Day 364
From first dose up to 72 weeks
Summary of Patient Global Assessment (PGA) for Treatment Satisfaction at > Day 364
From first dose up to 72 weeks
Summary of Patient Global Assessment (PGA) for Treatment Continuation at End of Treatment
From first dose up to 72 weeks
Study Arms (2)
Plecanatide 3.0 mg
EXPERIMENTALPlecanatide 3.0 mg, one tablet by mouth daily for 52 weeks
Plecanatide 6.0 mg
EXPERIMENTALPlecanatide 6.0 mg, one tablet by mouth daily for 52 weeks
Interventions
Eligibility Criteria
You may qualify if:
- Patient completed a previous double-blind plecanatide study and was compliant with the study requirements.
- Patient is in good health without unstable acute illness or exacerbation of an unstable chronic illness or chronic disease that may affect study assessments, particularly if there has been a significant change to health status since the previous plecanatide study.
You may not qualify if:
- Patient has had major surgery including laparoscopic procedures requiring general anesthesia within 60 days of Day 1.
- Patient has a medical history of hepatitis B, hepatitis C or human immunodeficiency virus (HIV) infection.
- Patient has taken a protocol-prohibited drug without the appropriate washout period.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Bausch Health Americas, Inc.lead
- Syneos Healthcollaborator
Study Sites (220)
Synergy Research Site
Birmingham, Alabama, 35242, United States
Synergy Research Site
Dothan, Alabama, 36305, United States
Synergy Research Site
Gulf Shores, Alabama, 36542, United States
Synergy Research Site
Huntsville, Alabama, 35801, United States
Synergy Research Site
Chandler, Arizona, 85224, United States
Synergy Research Site
Phoenix, Arizona, 85018, United States
Synergy Research Site
Tempe, Arizona, 85283, United States
Synergy Research Site
Tucson, Arizona, 85704, United States
Synergy Research Site
Tucson, Arizona, 85712, United States
Synergy Research Site
Tucson, Arizona, 85716, United States
Synergy Research Site
Little Rock, Arkansas, 72211, United States
Synergy Research Site
North Little Rock, Arkansas, 72117, United States
Synergy Research Site
Anaheim, California, 92801, United States
Synergy Research Site
Anaheim, California, 92804, United States
Synergy Research Site
Artesia, California, 90701, United States
Synergy Research Site
Carlsbad, California, 92008, United States
Synergy Research Site
Cerritos, California, 90703, United States
Synergy Research Site
Chula Vista, California, 91910, United States
Synergy Research Site
Corona, California, 92879, United States
Synergy Research Site
Encinitas, California, 92024, United States
Synergy Research Site
Fountain Valley, California, 92708, United States
Synergy Research Site
Fresno, California, 93726, United States
Synergy Research Site
Hawaiian Gardens, California, 90716, United States
Synergy Research Site
La Mirada, California, 90638, United States
Synergy Research Site
Laguna Hills, California, 92653, United States
Synergy Research Site
Lancaster, California, 93534, United States
Synergy Research Site
Long Beach, California, 90806, United States
Synergy Research Site
Los Angeles, California, 90015, United States
Synergy Research Site
Los Angeles, California, 90045, United States
Synergy Research Site
Mission Hills, California, 91345, United States
Synergy Research Site
North Hollywood, California, 91606, United States
Synergy Research Site
Orange, California, 92868, United States
Synergy Research Site
Pasadena, California, 91105, United States
Synergy Research Site
Sacramento, California, 95821, United States
Synergy Research Site
San Diego, California, 92103, United States
Synergy Research Site
San Diego, California, 92108, United States
Synergy Research Site
San Diego, California, 92114, United States
Synergy Research Site
Thousand Oaks, California, 91360, United States
Synergy Research Site
Colorado Springs, Colorado, 80904, United States
Synergy Research Site
Colorado Springs, Colorado, 80907, United States
Synergy Research Site
Colorado Springs, Colorado, 80909, United States
Synergy Research Site
Denver, Colorado, 80218, United States
Synergy Research Site
Denver, Colorado, 80220, United States
Synergy Research Site
Denver, Colorado, 80246, United States
Synergy Research Site
Littleton, Colorado, 80128, United States
Synergy Research Site
Bristol, Connecticut, 06010, United States
Synergy Research Site
Waterbury, Connecticut, 06708, United States
Synergy Research Site
Boynton Beach, Florida, 33426, United States
Synergy Research Site
Brandon, Florida, 33511, United States
Synergy Research Site
Clearwater, Florida, 33756, United States
Synergy Research Site
Clearwater, Florida, 33759, United States
Synergy Research Site
Cutler Bay, Florida, 33189, United States
Synergy Research Site
DeLand, Florida, 32720, United States
Synergy Research Site
Fort Lauderdale, Florida, 33306, United States
Synergy Research Site
Hialeah, Florida, 33012, United States
Synergy Research Site
Hialeah, Florida, 33013, United States
Synergy Research Site
Hialeah, Florida, 33016, United States
Synergy Research Site
Homestead, Florida, 33030, United States
Synergy Research Site
Jupiter, Florida, 33458, United States
Synergy Research Site
Lakeland, Florida, 33805, United States
Synergy Research Site
Miami, Florida, 33015, United States
Synergy Research Site
Miami, Florida, 33032, United States
Synergy Research Site
Miami, Florida, 33122, United States
Synergy Research Site
Miami, Florida, 33125, United States
Synergy Research Site
Miami, Florida, 33126, United States
Synergy Research Site
Miami, Florida, 33130, United States
Synergy Research Site
Miami, Florida, 33142, United States
Synergy Research Site
Miami, Florida, 33144, United States
Synergy Research Site
Miami, Florida, 33155, United States
Synergy Research Site
Miami, Florida, 33165, United States
Synergy Research Site
Miami, Florida, 33173, United States
Synergy Research Site
Miami, Florida, 33174, United States
Synergy Research Site
Miami, Florida, 33175, United States
Synergy Research Site
Miami, Florida, 33176, United States
Synergy Research Site
Miami, Florida, 33186, United States
Synergy Research Site
Miami Lakes, Florida, 33016, United States
Synergy Research Site
Miami Springs, Florida, 33166, United States
Synergy Research Site
Orlando, Florida, 32801, United States
Synergy Research Site
Orlando, Florida, 32806, United States
Synergy Research Site
Orlando, Florida, 32807, United States
Synergy Research Site
Pembroke Pines, Florida, 33026, United States
Synergy Research Site
Port Orange, Florida, 32129, United States
Synergy Research Site
St. Petersburg, Florida, 33709, United States
Synergy Research Site
Tamarac, Florida, 33319, United States
Synergy Research Site
Tampa, Florida, 33606, United States
Synergy Research Site
Tampa, Florida, 33607, United States
Synergy Research Site
West Palm Beach, Florida, 33409, United States
Synergy Research Site
Athens, Georgia, 30606, United States
Synergy Research Site
Atlanta, Georgia, 30342, United States
Synergy Research Site
Decatur, Georgia, 30032, United States
Synergy Research Site
Decatur, Georgia, 30033, United States
Synergy Research Site
Oakwood, Georgia, 30566, United States
Synergy Research Site
Sandy Springs, Georgia, 30328, United States
Synergy Research Site
Savannah, Georgia, 31406, United States
Synergy Research Site
Smyrna, Georgia, 30082, United States
Synergy Research Site
Snellville, Georgia, 30078, United States
Synergy Research Site
Blackfoot, Idaho, 83221, United States
Synergy Research Site
Chicago, Illinois, 60602, United States
Synergy Research Site
Brownsburg, Indiana, 46112, United States
Synergy Research Site
Clive, Iowa, 50325, United States
Synergy Research Site
Augusta, Kansas, 67010, United States
Synergy Research Site
Newton, Kansas, 67114, United States
Synergy Research Site
Shawnee Mission, Kansas, 66218, United States
Synergy Research Site
Wichita, Kansas, 67205, United States
Synergy Research Site
Wichita, Kansas, 67207, United States
Synergy Research Site
Lexington, Kentucky, 40503, United States
Synergy Research Site
Owensboro, Kentucky, 42303, United States
Synergy Research Site
Bastrop, Louisiana, 71220, United States
Synergy Research Site
Marrero, Louisiana, 70072, United States
Synergy Research Site
Metairie, Louisiana, 70006, United States
Synergy Research Site
New Orleans, Louisiana, 70115, United States
Synergy Research Site
New Orleans, Louisiana, 70119, United States
Synergy Research Site
Shreveport, Louisiana, 71103, United States
Synergy Research Site
Chevy Chase, Maryland, 20815, United States
Synergy Research Site
Boston, Massachusetts, 02131, United States
Synergy Research Site
New Bedford, Massachusetts, 02740, United States
Synergy Research Site
Chesterfield, Michigan, 48047, United States
Synergy Research Site
Flint, Michigan, 48504, United States
Synergy Research Site
Rochester, Michigan, 48307, United States
Synergy Research Site
Saginaw, Michigan, 48604, United States
Synergy Research Site
Southfield, Michigan, 48034, United States
Synergy Research Site
Biloxi, Mississippi, 39531, United States
Synergy Research Site
Jackson, Mississippi, 39202, United States
Synergy Research Site
St Louis, Missouri, 63128, United States
Synergy Research Site
Grand Island, Nebraska, 68803, United States
Synergy Research Site
Omaha, Nebraska, 68114, United States
Synergy Research Site
Henderson, Nevada, 89014, United States
Synergy Research Site
Las Vegas, Nevada, 89103, United States
Synergy Research Site
Las Vegas, Nevada, 89119, United States
Synergy Research Site
Las Vegas, Nevada, 89121, United States
Synergy Research Site
Reno, Nevada, 89511, United States
Synergy Research Site
Elizabeth, New Jersey, 07202, United States
Synergy Research Site
Lodi, New Jersey, 07644, United States
Synergy Research Site
Marlton, New Jersey, 08053, United States
Synergy Research Site
Albuquerque, New Mexico, 87108, United States
Synergy Research Site
Albuquerque, New Mexico, 87109, United States
Synergy Research Site
Brooklyn, New York, 11206, United States
Synergy Research Site
Great Neck, New York, 11023, United States
Synergy Research Site
New York, New York, 10016, United States
Synergy Research Site
Poughkeepsie, New York, 12601, United States
Synergy Research Site
Cary, North Carolina, 27518, United States
Synergy Research Site
Chapel Hill, North Carolina, 27599, United States
Synergy Research Site
Charlotte, North Carolina, 28210, United States
Synergy Research Site
Charlotte, North Carolina, 28277, United States
Synergy Research Site
Greensboro, North Carolina, 27403, United States
Synergy Research Site
Kinston, North Carolina, 28501, United States
Synergy Research Site
Raleigh, North Carolina, 27612, United States
Synergy Research Site
Wilmington, North Carolina, 28401, United States
Synergy Research Site
Winston-Salem, North Carolina, 27103, United States
Synergy Research Site
Fargo, North Dakota, 58103, United States
Synergy Research Site
Beavercreek, Ohio, 45432, United States
Synergy Research Site
Centerville, Ohio, 45459, United States
Synergy Research Site
Cincinnati, Ohio, 45224, United States
Synergy Research Site
Cincinnati, Ohio, 45246, United States
Synergy Research Site
Cleveland, Ohio, 44122, United States
Synergy Research Site
Huber Heights, Ohio, 45424, United States
Synergy Research Site
Maumee, Ohio, 43537, United States
Synergy Research Site
Mentor, Ohio, 44060, United States
Synergy Research Site
Oakwood, Ohio, 45419, United States
Synergy Research Site
Stow, Ohio, 44224, United States
Synergy Research Site
Norman, Oklahoma, 73071, United States
Synergy Research Site
Oklahoma City, Oklahoma, 73102, United States
Synergy Research Site
Oklahoma City, Oklahoma, 73104, United States
Synergy Research Site
Levittown, Pennsylvania, 19056, United States
Synergy Research Site
Limerick, Pennsylvania, 19468, United States
Synergy Research Site
Philadelphia, Pennsylvania, 19152, United States
Synergy Research Site
Pittsburgh, Pennsylvania, 15206, United States
Synergy Research Site
Yardley, Pennsylvania, 19067, United States
Synergy Research Site
Anderson, South Carolina, 29621, United States
Synergy Research Site
Charleston, South Carolina, 29406, United States
Synergy Research Site
Columbia, South Carolina, 29203, United States
Synergy Research Site
Chattanooga, Tennessee, 37421, United States
Synergy Research Site
Franklin, Tennessee, 37064, United States
Synergy Research Site
Jackson, Tennessee, 38305, United States
Synergy Research Site
Knoxville, Tennessee, 37912, United States
Synergy Research Site
Memphis, Tennessee, 38119, United States
Synergy Research Site
Nashville, Tennessee, 37211, United States
Synergy Research Site
New Tazewell, Tennessee, 37825, United States
Synergy Research Site
Arlington, Texas, 76012, United States
Synergy Research Site
Austin, Texas, 78731, United States
Synergy Research Site
Austin, Texas, 78745, United States
Synergy Research Site
Channelview, Texas, 77530, United States
Synergy Research Site
Dallas, Texas, 75230, United States
Synergy Research Site
Dallas, Texas, 75234, United States
Synergy Research Site
Houston, Texas, 77034, United States
Synergy Research Site
Houston, Texas, 77043, United States
Synergy Research Site
Houston, Texas, 77062, United States
Synergy Research Site
Houston, Texas, 77070, United States
Synergy Research Site
Houston, Texas, 77090, United States
Synergy Research Site
Houston, Texas, 77099, United States
Synergy Research Site
Humble, Texas, 77338, United States
Synergy Research Site
Katy, Texas, 77450, United States
Synergy Research Site
Plano, Texas, 75093, United States
Synergy Research Site
San Antonio, Texas, 78209, United States
Synergy Research Site
San Antonio, Texas, 78215, United States
Synergy Research Site
Sugar Land, Texas, 77479, United States
Synergy Research Site
Logan, Utah, 84341, United States
Synergy Research Site
Salt Lake City, Utah, 84124, United States
Synergy Research Site
St. George, Utah, 84790, United States
Synergy Research Site
West Jordan, Utah, 84088, United States
Synergy Research Site
Christiansburg, Virginia, 24073, United States
Synergy Research Site
Henrico, Virginia, 23233, United States
Synergy Research Site
Lynchburg, Virginia, 24502, United States
Synergy Research Site
Newport News, Virginia, 23606, United States
Synergy Research Site
Norfolk, Virginia, 23502, United States
Synergy Research Site
Norfolk, Virginia, 23507, United States
Synergy Research Site
Richmond, Virginia, 23294, United States
Synergy Research Site
Richland, Washington, 99352, United States
Synergy Research Site
Seattle, Washington, 98105, United States
Synergy Research Site
Tacoma, Washington, 98405, United States
Synergy Research Site
Wauwatosa, Wisconsin, 53226, United States
Synergy Research Site
Kelowna, British Columbia, V1Y 1Z9, Canada
Synergy Research Site
Bridgewater, Nova Scotia, B4V 3N2, Canada
Synergy Research Site
Cambridge, Ontario, N1S 2M6, Canada
Synergy Research Site
Greater Sudbury, Ontario, P3A 1Y8, Canada
Synergy Research Site
Toronto, Ontario, M3J 2C5, Canada
Synergy Research Site
Toronto, Ontario, M9W 4L6, Canada
Synergy Research Site
Mirabel, Quebec, J7J 2K8, Canada
Synergy Research Site
Pointe-Claire, Quebec, H9R 4S3, Canada
Synergy Research Site
Saint Romuald, Quebec, G6W 5M6, Canada
Related Publications (1)
Barish CF, Griffin P. Safety and tolerability of plecanatide in patients with chronic idiopathic constipation: long-term evidence from an open-label study. Curr Med Res Opin. 2018 Apr;34(4):751-755. doi: 10.1080/03007995.2018.1430024. Epub 2018 Feb 2.
PMID: 29343131DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Patrick H. Griffin
- Organization
- Synergy Pharmaceuticals Inc.
Study Officials
- PRINCIPAL INVESTIGATOR
Richard A Krause, MD
ClinSearch, LLC
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 7, 2013
First Posted
August 9, 2013
Study Start
August 1, 2013
Primary Completion
January 1, 2016
Study Completion
March 1, 2016
Last Updated
July 2, 2019
Results First Posted
July 2, 2019
Record last verified: 2019-06